Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Purchased by Avior Wealth Management LLC

Avior Wealth Management LLC boosted its stake in shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) by 1,118.1% in the third quarter, HoldingsChannel.com reports. The fund owned 14,569 shares of the medical instruments supplier’s stock after purchasing an additional 13,373 shares during the period. Avior Wealth Management LLC’s holdings in Harvard Bioscience were worth $39,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. GSA Capital Partners LLP acquired a new stake in shares of Harvard Bioscience in the third quarter worth approximately $30,000. Allspring Global Investments Holdings LLC acquired a new stake in Harvard Bioscience during the 2nd quarter worth $31,000. SG Americas Securities LLC purchased a new stake in shares of Harvard Bioscience during the third quarter worth $36,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Harvard Bioscience in the second quarter valued at about $40,000. Finally, Price T Rowe Associates Inc. MD purchased a new position in shares of Harvard Bioscience in the first quarter worth about $54,000. 80.87% of the stock is currently owned by institutional investors and hedge funds.

Harvard Bioscience Stock Down 1.3 %

Shares of NASDAQ HBIO opened at $2.24 on Tuesday. The stock has a market cap of $97.71 million, a PE ratio of -6.79 and a beta of 1.31. The company has a current ratio of 2.06, a quick ratio of 0.91 and a debt-to-equity ratio of 0.52. Harvard Bioscience, Inc. has a 12-month low of $1.99 and a 12-month high of $5.56. The company has a 50-day moving average of $2.45 and a 200 day moving average of $2.82.

Harvard Bioscience Profile

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.